[
  {
    "title": "Contact UsCareersSHAREPipelineAlloCAR T\u2122 Product PipelineDATABRIEFExpanded AccessScientific PublicationsScienceNext Revolution in Cell TherapyPlatform",
    "link": "https://www.allogene.com/contact-us",
    "timestamp": "unknown"
  },
  {
    "title": "Contact UsCareersSHARE",
    "link": "https://www.allogene.com/contact-us",
    "timestamp": "unknown"
  },
  {
    "title": "Contact UsCareersSHARE",
    "link": "https://www.allogene.com/contact-us",
    "timestamp": "unknown"
  },
  {
    "title": "Contact UsCareersSHARE",
    "link": "https://www.allogene.com/contact-us",
    "timestamp": "unknown"
  },
  {
    "title": "Contact Us",
    "link": "https://www.allogene.com/contact-us",
    "timestamp": "unknown"
  },
  {
    "title": "Careers",
    "link": "https://www.allogene.com/careers",
    "timestamp": "unknown"
  },
  {
    "title": "PipelineAlloCAR T\u2122 Product PipelineDATABRIEFExpanded AccessScientific PublicationsScienceNext Revolution in Cell TherapyPlatform for TomorrowOn-demand",
    "link": "https://www.allogene.com/",
    "timestamp": "unknown"
  },
  {
    "title": "PipelineAlloCAR T\u2122 Product PipelineDATABRIEFExpanded AccessScientific PublicationsScienceNext Revolution in Cell TherapyPlatform for TomorrowOn-demand",
    "link": "https://www.allogene.com/pipeline",
    "timestamp": "unknown"
  },
  {
    "title": "PipelineAlloCAR T\u2122 Product PipelineDATABRIEFExpanded AccessScientific Publications",
    "link": "https://www.allogene.com/pipeline",
    "timestamp": "unknown"
  },
  {
    "title": "AlloCAR T\u2122 Product Pipeline",
    "link": "https://allogene.com/pipeline/#allocart-pipeline",
    "timestamp": "unknown"
  },
  {
    "title": "DATABRIEF",
    "link": "https://allogene.com/pipeline/#databrief",
    "timestamp": "unknown"
  },
  {
    "title": "Expanded Access",
    "link": "https://www.allogene.com/pipeline#expanded-access",
    "timestamp": "unknown"
  },
  {
    "title": "Scientific Publications",
    "link": "https://www.allogene.com/pipeline#scientific-publications",
    "timestamp": "unknown"
  },
  {
    "title": "ScienceNext Revolution in Cell TherapyPlatform for TomorrowOn-demand Availability",
    "link": "https://allogene.com//science",
    "timestamp": "unknown"
  },
  {
    "title": "Next Revolution in Cell Therapy",
    "link": "https://www.allogene.com/allocar-t-therapy#next-revolution-cell-therapy",
    "timestamp": "unknown"
  },
  {
    "title": "Platform for Tomorrow",
    "link": "https://www.allogene.com/allocar-t-therapy#platform-for-tomorrow",
    "timestamp": "unknown"
  },
  {
    "title": "On-demand Availability",
    "link": "https://www.allogene.com/allocar-t-therapy#on-demand-availability",
    "timestamp": "unknown"
  },
  {
    "title": "About UsAt A GlanceManagement TeamBoard of DirectorsScientific AdvisorsPartnersCorporate Responsibility",
    "link": "https://www.allogene.com/about-us",
    "timestamp": "unknown"
  },
  {
    "title": "At A Glance",
    "link": "https://www.allogene.com/about-us#at-a-glance",
    "timestamp": "unknown"
  },
  {
    "title": "Management Team",
    "link": "https://www.allogene.com/about-us#management-team",
    "timestamp": "unknown"
  },
  {
    "title": "Board of Directors",
    "link": "https://www.allogene.com/about-us#board-of-directors",
    "timestamp": "unknown"
  },
  {
    "title": "Scientific Advisors",
    "link": "https://www.allogene.com/about-us#scientific-advisors",
    "timestamp": "unknown"
  },
  {
    "title": "Partners",
    "link": "https://www.allogene.com/about-us#our-partners",
    "timestamp": "unknown"
  },
  {
    "title": "Corporate Responsibility",
    "link": "https://allogene.com/about-us/#responsibility",
    "timestamp": "unknown"
  },
  {
    "title": "News CenterPress ReleasesEventsPerspectivesSocial MediaCommunity Guidelines",
    "link": "https://www.allogene.com/news-center",
    "timestamp": "unknown"
  },
  {
    "title": "Press Releases",
    "link": "https://www.allogene.com/news-center#press-releases",
    "timestamp": "unknown"
  },
  {
    "title": "Events",
    "link": "https://www.allogene.com/news-center#events",
    "timestamp": "unknown"
  },
  {
    "title": "Perspectives",
    "link": "https://www.allogene.com/news-center#perspectives",
    "timestamp": "unknown"
  },
  {
    "title": "Social Media",
    "link": "https://www.allogene.com/news-center#our-tweets",
    "timestamp": "unknown"
  },
  {
    "title": "Community Guidelines",
    "link": "https://www.allogene.com/news-center#community-guidelines",
    "timestamp": "unknown"
  },
  {
    "title": "INVESTORSIR OverviewNews & EventsPress ReleasesEventsPresentationsStock InformationStock Quote & ChartHistorical Price LookupInvestment CalculatorCorp",
    "link": "https://ir.allogene.com/investor-relations",
    "timestamp": "unknown"
  },
  {
    "title": "IR Overview",
    "link": "https://ir.allogene.com/investor-relations",
    "timestamp": "unknown"
  },
  {
    "title": "News & EventsPress ReleasesEventsPresentations",
    "link": "https://ir.allogene.com/press-releases",
    "timestamp": "unknown"
  },
  {
    "title": "Press Releases",
    "link": "https://ir.allogene.com/press-releases",
    "timestamp": "unknown"
  },
  {
    "title": "Events",
    "link": "https://ir.allogene.com/events",
    "timestamp": "unknown"
  },
  {
    "title": "Presentations",
    "link": "https://ir.allogene.com/presentations",
    "timestamp": "unknown"
  },
  {
    "title": "Stock InformationStock Quote & ChartHistorical Price LookupInvestment Calculator",
    "link": "https://ir.allogene.com/stock-quote-chart",
    "timestamp": "unknown"
  },
  {
    "title": "Stock Quote & Chart",
    "link": "https://ir.allogene.com/stock-quote-chart",
    "timestamp": "unknown"
  },
  {
    "title": "Historical Price Lookup",
    "link": "https://ir.allogene.com/historic-price-lookup",
    "timestamp": "unknown"
  },
  {
    "title": "Investment Calculator",
    "link": "https://ir.allogene.com/investment-calculator",
    "timestamp": "unknown"
  },
  {
    "title": "Corporate GovernanceDocuments and ChartersBoard of DirectorsManagementCommittee Composition",
    "link": "https://ir.allogene.com/Documents-and-Charters",
    "timestamp": "unknown"
  },
  {
    "title": "Documents and Charters",
    "link": "https://ir.allogene.com/Documents-and-Charters",
    "timestamp": "unknown"
  },
  {
    "title": "Board of Directors",
    "link": "https://www.allogene.com/about-us#board-of-directors",
    "timestamp": "unknown"
  },
  {
    "title": "Management",
    "link": "https://www.allogene.com/about-us#management-team",
    "timestamp": "unknown"
  },
  {
    "title": "Committee Composition",
    "link": "https://ir.allogene.com/committee-composition",
    "timestamp": "unknown"
  },
  {
    "title": "SEC Filings",
    "link": "https://ir.allogene.com/sec-filings",
    "timestamp": "unknown"
  },
  {
    "title": "ResourcesInvestor FAQsEmail AlertsIR Inquiry",
    "link": "https://ir.allogene.com/investor-faqs",
    "timestamp": "unknown"
  },
  {
    "title": "Investor FAQs",
    "link": "https://ir.allogene.com/investor-faqs",
    "timestamp": "unknown"
  },
  {
    "title": "Email Alerts",
    "link": "https://ir.allogene.com/email-alerts",
    "timestamp": "unknown"
  },
  {
    "title": "IR Inquiry",
    "link": "https://ir.allogene.com/investor-contacts",
    "timestamp": "unknown"
  },
  {
    "title": "Press ReleasesYearNone20252024202320222021202020192018Jun 01, 2025Allogene Therapeutics Provides Updated Phase 1 Data Highlighting Durable Responses w",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-provides-updated-phase-1-data-highlighting",
    "timestamp": "unknown"
  },
  {
    "title": "YearNone20252024202320222021202020192018Jun 01, 2025Allogene Therapeutics Provides Updated Phase 1 Data Highlighting Durable Responses with ALLO-316 i",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-provides-updated-phase-1-data-highlighting",
    "timestamp": "unknown"
  },
  {
    "title": "YearNone20252024202320222021202020192018Jun 01, 2025Allogene Therapeutics Provides Updated Phase 1 Data Highlighting Durable Responses with ALLO-316 i",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-provides-updated-phase-1-data-highlighting",
    "timestamp": "unknown"
  },
  {
    "title": "YearNone20252024202320222021202020192018Jun 01, 2025Allogene Therapeutics Provides Updated Phase 1 Data Highlighting Durable Responses with ALLO-316 i",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-provides-updated-phase-1-data-highlighting",
    "timestamp": "unknown"
  },
  {
    "title": "YearNone20252024202320222021202020192018Jun 01, 2025Allogene Therapeutics Provides Updated Phase 1 Data Highlighting Durable Responses with ALLO-316 i",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-provides-updated-phase-1-data-highlighting",
    "timestamp": "unknown"
  },
  {
    "title": "YearNone20252024202320222021202020192018Jun 01, 2025Allogene Therapeutics Provides Updated Phase 1 Data Highlighting Durable Responses with ALLO-316 i",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-provides-updated-phase-1-data-highlighting",
    "timestamp": "unknown"
  },
  {
    "title": "YearNone20252024202320222021202020192018Jun 01, 2025Allogene Therapeutics Provides Updated Phase 1 Data Highlighting Durable Responses with ALLO-316 i",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-provides-updated-phase-1-data-highlighting",
    "timestamp": "unknown"
  },
  {
    "title": "YearNone20252024202320222021202020192018Jun 01, 2025Allogene Therapeutics Provides Updated Phase 1 Data Highlighting Durable Responses with ALLO-316 i",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-provides-updated-phase-1-data-highlighting",
    "timestamp": "unknown"
  },
  {
    "title": "YearNone20252024202320222021202020192018Jun 01, 2025Allogene Therapeutics Provides Updated Phase 1 Data Highlighting Durable Responses with ALLO-316 i",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-provides-updated-phase-1-data-highlighting",
    "timestamp": "unknown"
  },
  {
    "title": "YearNone20252024202320222021202020192018Jun 01, 2025Allogene Therapeutics Provides Updated Phase 1 Data Highlighting Durable Responses with ALLO-316 i",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-provides-updated-phase-1-data-highlighting",
    "timestamp": "unknown"
  },
  {
    "title": "YearNone20252024202320222021202020192018Jun 01, 2025Allogene Therapeutics Provides Updated Phase 1 Data Highlighting Durable Responses with ALLO-316 i",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-provides-updated-phase-1-data-highlighting",
    "timestamp": "unknown"
  },
  {
    "title": "YearNone20252024202320222021202020192018Jun 01, 2025Allogene Therapeutics Provides Updated Phase 1 Data Highlighting Durable Responses with ALLO-316 i",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-provides-updated-phase-1-data-highlighting",
    "timestamp": "unknown"
  },
  {
    "title": "YearNone20252024202320222021202020192018Jun 01, 2025Allogene Therapeutics Provides Updated Phase 1 Data Highlighting Durable Responses with ALLO-316 i",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-provides-updated-phase-1-data-highlighting",
    "timestamp": "unknown"
  },
  {
    "title": "YearNone20252024202320222021202020192018Jun 01, 2025Allogene Therapeutics Provides Updated Phase 1 Data Highlighting Durable Responses with ALLO-316 i",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-provides-updated-phase-1-data-highlighting",
    "timestamp": "unknown"
  },
  {
    "title": "YearNone20252024202320222021202020192018Jun 01, 2025Allogene Therapeutics Provides Updated Phase 1 Data Highlighting Durable Responses with ALLO-316 i",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-provides-updated-phase-1-data-highlighting",
    "timestamp": "unknown"
  },
  {
    "title": "YearNone20252024202320222021202020192018Jun 01, 2025Allogene Therapeutics Provides Updated Phase 1 Data Highlighting Durable Responses with ALLO-316 i",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-provides-updated-phase-1-data-highlighting",
    "timestamp": "unknown"
  },
  {
    "title": "YearNone20252024202320222021202020192018Jun 01, 2025Allogene Therapeutics Provides Updated Phase 1 Data Highlighting Durable Responses with ALLO-316 i",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-provides-updated-phase-1-data-highlighting",
    "timestamp": "unknown"
  },
  {
    "title": "YearNone20252024202320222021202020192018Jun 01, 2025Allogene Therapeutics Provides Updated Phase 1 Data Highlighting Durable Responses with ALLO-316 i",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-provides-updated-phase-1-data-highlighting",
    "timestamp": "unknown"
  },
  {
    "title": "YearNone20252024202320222021202020192018Jun 01, 2025Allogene Therapeutics Provides Updated Phase 1 Data Highlighting Durable Responses with ALLO-316 i",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-provides-updated-phase-1-data-highlighting",
    "timestamp": "unknown"
  },
  {
    "title": "Jun 01, 2025Allogene Therapeutics Provides Updated Phase 1 Data Highlighting Durable Responses with ALLO-316 in Heavily Pretreated Advanced Renal Cell",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-provides-updated-phase-1-data-highlighting",
    "timestamp": "unknown"
  },
  {
    "title": "Jun 01, 2025Allogene Therapeutics Provides Updated Phase 1 Data Highlighting Durable Responses with ALLO-316 in Heavily Pretreated Advanced Renal Cell",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-provides-updated-phase-1-data-highlighting",
    "timestamp": "unknown"
  },
  {
    "title": "Allogene Therapeutics Provides Updated Phase 1 Data Highlighting Durable Responses with ALLO-316 in Heavily Pretreated Advanced Renal Cell Carcinoma a",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-provides-updated-phase-1-data-highlighting",
    "timestamp": "unknown"
  },
  {
    "title": "May 23, 2025Allogene Therapeutics Announces Participation in Upcoming Investor ConferencesSOUTH SAN FRANCISCO, Calif. , May 23, 2025 (GLOBE NEWSWIRE) ",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-announces-participation-upcoming-1",
    "timestamp": "unknown"
  },
  {
    "title": "Allogene Therapeutics Announces Participation in Upcoming Investor Conferences",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-announces-participation-upcoming-1",
    "timestamp": "unknown"
  },
  {
    "title": "May 22, 2025Allogene Therapeutics Announces ASCO 2025 Abstract Publication Featuring Oral Presentation of ALLO-316 in Kidney Cancer and ALPHA3 TIP Pos",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-announces-asco-2025-abstract-publication",
    "timestamp": "unknown"
  },
  {
    "title": "Allogene Therapeutics Announces ASCO 2025 Abstract Publication Featuring Oral Presentation of ALLO-316 in Kidney Cancer and ALPHA3 TIP Poster for Cema",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-announces-asco-2025-abstract-publication",
    "timestamp": "unknown"
  },
  {
    "title": "May 13, 2025Allogene Therapeutics Reports First Quarter 2025 Financial Results\u00a0and Business UpdatePivotal Phase 2 ALPHA3 Trial with Cemacabtagene Anse",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-reports-first-quarter-2025-financial",
    "timestamp": "unknown"
  },
  {
    "title": "Allogene Therapeutics Reports First Quarter 2025 Financial Results\u00a0and Business Update",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-reports-first-quarter-2025-financial",
    "timestamp": "unknown"
  },
  {
    "title": "May 06, 2025Allogene Therapeutics to Report First Quarter 2025 Financial Results and Provide Business UpdateConference Call and Webcast Scheduled for ",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-report-first-quarter-2025-financial",
    "timestamp": "unknown"
  },
  {
    "title": "Allogene Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-report-first-quarter-2025-financial",
    "timestamp": "unknown"
  },
  {
    "title": "Apr 23, 2025Allogene Therapeutics to Present Updated ALLO-316 Clinical Results in Kidney Cancer in Oral Presentation and ALPHA3 Trial-in-Progress Post",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-present-updated-allo-316-clinical-results",
    "timestamp": "unknown"
  },
  {
    "title": "Allogene Therapeutics to Present Updated ALLO-316 Clinical Results in Kidney Cancer in Oral Presentation and ALPHA3 Trial-in-Progress Poster for Cema-",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-present-updated-allo-316-clinical-results",
    "timestamp": "unknown"
  },
  {
    "title": "Apr 07, 2025Allogene Granted Three U.S. FDA Fast Track Designations (FTD) for ALLO-329, a Next-Generation Dual-Targeted CD19/CD70 Allogeneic CAR T, fo",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-granted-three-us-fda-fast-track-designations-ftd-allo",
    "timestamp": "unknown"
  },
  {
    "title": "Allogene Granted Three U.S. FDA Fast Track Designations (FTD) for ALLO-329, a Next-Generation Dual-Targeted CD19/CD70 Allogeneic CAR T, for the Treatm",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-granted-three-us-fda-fast-track-designations-ftd-allo",
    "timestamp": "unknown"
  },
  {
    "title": "Mar 13, 2025Allogene Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business UpdateMomentum Builds Across Programs with ",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-reports-fourth-quarter-and-full-year-2024",
    "timestamp": "unknown"
  },
  {
    "title": "Allogene Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Update",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-reports-fourth-quarter-and-full-year-2024",
    "timestamp": "unknown"
  },
  {
    "title": "Mar 03, 2025Allogene Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business UpdateConference Call and Webcast",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-report-fourth-quarter-and-full-year-2024",
    "timestamp": "unknown"
  },
  {
    "title": "Allogene Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-report-fourth-quarter-and-full-year-2024",
    "timestamp": "unknown"
  },
  {
    "title": "Feb 26, 2025Allogene Therapeutics Announces Participation in March Investor ConferenceSOUTH SAN FRANCISCO, Calif. , Feb. 26, 2025 (GLOBE NEWSWIRE) -- ",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-announces-participation-march-investor",
    "timestamp": "unknown"
  },
  {
    "title": "Allogene Therapeutics Announces Participation in March Investor Conference",
    "link": "https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-announces-participation-march-investor",
    "timestamp": "unknown"
  },
  {
    "title": "PaginationCurrent page1Page2Next pagenext \u203aLast pagelast \u00bb",
    "link": "https://ir.allogene.com/press-releases?page=0",
    "timestamp": "unknown"
  },
  {
    "title": "Current page1",
    "link": "https://ir.allogene.com/press-releases?page=0",
    "timestamp": "unknown"
  },
  {
    "title": "Page2",
    "link": "https://ir.allogene.com/press-releases?page=1",
    "timestamp": "unknown"
  },
  {
    "title": "Next pagenext \u203a",
    "link": "https://ir.allogene.com/press-releases?page=1",
    "timestamp": "unknown"
  },
  {
    "title": "Last pagelast \u00bb",
    "link": "https://ir.allogene.com/press-releases?page=1",
    "timestamp": "unknown"
  },
  {
    "title": "Print PageEmail AlertsRSS FeedsInvestor Contacts",
    "link": "https://ir.allogene.com/press-releases",
    "timestamp": "unknown"
  },
  {
    "title": "Print PageEmail AlertsRSS FeedsInvestor Contacts",
    "link": "https://ir.allogene.com/press-releases",
    "timestamp": "unknown"
  },
  {
    "title": "Print PageEmail AlertsRSS FeedsInvestor Contacts",
    "link": "https://ir.allogene.com/press-releases",
    "timestamp": "unknown"
  },
  {
    "title": "Print Page",
    "link": "https://ir.allogene.com/press-releases",
    "timestamp": "unknown"
  },
  {
    "title": "Print Page",
    "link": "https://ir.allogene.com/press-releases",
    "timestamp": "unknown"
  },
  {
    "title": "Email Alerts",
    "link": "https://ir.allogene.com/email-alerts",
    "timestamp": "unknown"
  },
  {
    "title": "Email Alerts",
    "link": "https://ir.allogene.com/email-alerts",
    "timestamp": "unknown"
  },
  {
    "title": "RSS Feeds",
    "link": "https://ir.allogene.com/shareholder-services/rss-feeds",
    "timestamp": "unknown"
  },
  {
    "title": "RSS Feeds",
    "link": "https://ir.allogene.com/shareholder-services/rss-feeds",
    "timestamp": "unknown"
  },
  {
    "title": "Investor Contacts",
    "link": "https://ir.allogene.com/investor-contacts",
    "timestamp": "unknown"
  },
  {
    "title": "Investor Contacts",
    "link": "https://ir.allogene.com/investor-contacts",
    "timestamp": "unknown"
  },
  {
    "title": "\u00d7FacebookTwitterLinkedInE-MailTumblrRedditWhatsAppTelegram",
    "link": "https://facebook.com/sharer/sharer.php?u=https://ir.allogene.com",
    "timestamp": "unknown"
  },
  {
    "title": "\u00d7FacebookTwitterLinkedInE-MailTumblrRedditWhatsAppTelegram",
    "link": "https://facebook.com/sharer/sharer.php?u=https://ir.allogene.com",
    "timestamp": "unknown"
  },
  {
    "title": "\u00d7FacebookTwitterLinkedInE-MailTumblrRedditWhatsAppTelegram",
    "link": "https://facebook.com/sharer/sharer.php?u=https://ir.allogene.com",
    "timestamp": "unknown"
  },
  {
    "title": "\u00d7FacebookTwitterLinkedInE-MailTumblrRedditWhatsAppTelegram",
    "link": "https://facebook.com/sharer/sharer.php?u=https://ir.allogene.com",
    "timestamp": "unknown"
  },
  {
    "title": "\u00d7FacebookTwitterLinkedInE-MailTumblrRedditWhatsAppTelegram",
    "link": "https://facebook.com/sharer/sharer.php?u=https://ir.allogene.com",
    "timestamp": "unknown"
  },
  {
    "title": "CONNECT210 E. Grand AvenueSouth San Francisco, CA 94080View Map/Contact UsPipelineAlloCAR T\u2122 Product PipelineDATABRIEFExpanded AccessScientific Public",
    "link": "https://ir.allogene.com/press-releases",
    "timestamp": "unknown"
  },
  {
    "title": "CONNECT210 E. Grand AvenueSouth San Francisco, CA 94080View Map/Contact UsPipelineAlloCAR T\u2122 Product PipelineDATABRIEFExpanded AccessScientific Public",
    "link": "https://ir.allogene.com/press-releases",
    "timestamp": "unknown"
  },
  {
    "title": "CONNECT210 E. Grand AvenueSouth San Francisco, CA 94080View Map/Contact Us",
    "link": "https://ir.allogene.com/press-releases",
    "timestamp": "unknown"
  },
  {
    "title": "CONNECT210 E. Grand AvenueSouth San Francisco, CA 94080View Map/Contact Us",
    "link": "https://ir.allogene.com/press-releases",
    "timestamp": "unknown"
  },
  {
    "title": "CONNECT210 E. Grand AvenueSouth San Francisco, CA 94080View Map/Contact Us",
    "link": "https://ir.allogene.com/press-releases",
    "timestamp": "unknown"
  },
  {
    "title": "View Map/Contact Us",
    "link": "https://ir.allogene.com/press-releases",
    "timestamp": "unknown"
  },
  {
    "title": "PipelineAlloCAR T\u2122 Product PipelineDATABRIEFExpanded AccessScientific PublicationsScienceNext Revolution in Cell TherapyPlatform for TomorrowOn-Demand",
    "link": "https://www.allogene.com/pipeline",
    "timestamp": "unknown"
  },
  {
    "title": "Pipeline",
    "link": "https://www.allogene.com/pipeline",
    "timestamp": "unknown"
  },
  {
    "title": "AlloCAR T\u2122 Product Pipeline",
    "link": "https://allogene.com/pipeline#allocart-pipeline",
    "timestamp": "unknown"
  },
  {
    "title": "DATABRIEF",
    "link": "https://allogene.com/pipeline/#databrief",
    "timestamp": "unknown"
  },
  {
    "title": "Expanded Access",
    "link": "https://www.allogene.com/pipeline#expanded-access",
    "timestamp": "unknown"
  },
  {
    "title": "Scientific Publications",
    "link": "https://www.allogene.com/pipeline#scientific-publications",
    "timestamp": "unknown"
  },
  {
    "title": "Science",
    "link": "https://allogene.com/science/",
    "timestamp": "unknown"
  },
  {
    "title": "Next Revolution in Cell Therapy",
    "link": "https://allogene.com/science/#next-revolution-cell-therapy",
    "timestamp": "unknown"
  },
  {
    "title": "Platform for Tomorrow",
    "link": "https://allogene.com/science/#platform",
    "timestamp": "unknown"
  },
  {
    "title": "On-Demand Availability",
    "link": "https://allogene.com/science/#ondemand",
    "timestamp": "unknown"
  },
  {
    "title": "About UsAt a GlanceManagement TeamBoard of DirectorsScientific AdvisorsPartnersCorporate ResponsibilityNews CenterPress ReleasesEventsPerspectivesSoci",
    "link": "https://www.allogene.com/about-us",
    "timestamp": "unknown"
  },
  {
    "title": "About UsAt a GlanceManagement TeamBoard of DirectorsScientific AdvisorsPartnersCorporate Responsibility",
    "link": "https://www.allogene.com/about-us",
    "timestamp": "unknown"
  },
  {
    "title": "About Us",
    "link": "https://www.allogene.com/about-us",
    "timestamp": "unknown"
  },
  {
    "title": "At a Glance",
    "link": "https://www.allogene.com/about-us#at-a-glance",
    "timestamp": "unknown"
  },
  {
    "title": "Management Team",
    "link": "https://www.allogene.com/about-us#management-team",
    "timestamp": "unknown"
  },
  {
    "title": "Board of Directors",
    "link": "https://www.allogene.com/about-us#board-of-directors",
    "timestamp": "unknown"
  },
  {
    "title": "Scientific Advisors",
    "link": "https://www.allogene.com/about-us#scientific-advisors",
    "timestamp": "unknown"
  },
  {
    "title": "Partners",
    "link": "https://www.allogene.com/about-us#our-partners",
    "timestamp": "unknown"
  },
  {
    "title": "Corporate Responsibility",
    "link": "https://allogene.com/about-us/#responsibility",
    "timestamp": "unknown"
  },
  {
    "title": "News CenterPress ReleasesEventsPerspectivesSocial MediaCommunity Guidelines",
    "link": "https://www.allogene.com/news-center",
    "timestamp": "unknown"
  },
  {
    "title": "News Center",
    "link": "https://www.allogene.com/news-center",
    "timestamp": "unknown"
  },
  {
    "title": "Press Releases",
    "link": "https://www.allogene.com/news-center#press-releases",
    "timestamp": "unknown"
  },
  {
    "title": "Events",
    "link": "https://www.allogene.com/news-center#events",
    "timestamp": "unknown"
  },
  {
    "title": "Perspectives",
    "link": "https://www.allogene.com/news-center#perspectives",
    "timestamp": "unknown"
  },
  {
    "title": "Social Media",
    "link": "https://www.allogene.com/news-center#our-tweets",
    "timestamp": "unknown"
  },
  {
    "title": "Community Guidelines",
    "link": "https://www.allogene.com/news-center#community-guidelines",
    "timestamp": "unknown"
  },
  {
    "title": "InvestorsPress ReleasesEventsPresentationsStock InformationStock Quote & ChartHistorical Price Look UpInvestment CalculatorCorporate GovernanceDocumen",
    "link": "https://ir.allogene.com/investor-relations",
    "timestamp": "unknown"
  },
  {
    "title": "InvestorsPress ReleasesEventsPresentationsStock InformationStock Quote & ChartHistorical Price Look UpInvestment CalculatorCorporate GovernanceDocumen",
    "link": "https://ir.allogene.com/investor-relations",
    "timestamp": "unknown"
  },
  {
    "title": "Investors",
    "link": "https://ir.allogene.com/investor-relations",
    "timestamp": "unknown"
  },
  {
    "title": "Press Releases",
    "link": "https://ir.allogene.com/press-releases",
    "timestamp": "unknown"
  },
  {
    "title": "Events",
    "link": "https://ir.allogene.com/events",
    "timestamp": "unknown"
  },
  {
    "title": "Presentations",
    "link": "https://ir.allogene.com/presentations",
    "timestamp": "unknown"
  },
  {
    "title": "Stock Information",
    "link": "https://ir.allogene.com/stock-quote-chart",
    "timestamp": "unknown"
  },
  {
    "title": "Stock Quote & Chart",
    "link": "https://allogene.gcs-web.com/stock-quote-chart",
    "timestamp": "unknown"
  },
  {
    "title": "Historical Price Look Up",
    "link": "https://ir.allogene.com/historic-price-lookup",
    "timestamp": "unknown"
  },
  {
    "title": "Investment Calculator",
    "link": "https://ir.allogene.com/investment-calculator",
    "timestamp": "unknown"
  },
  {
    "title": "Corporate Governance",
    "link": "https://ir.allogene.com/Documents-and-Charters",
    "timestamp": "unknown"
  },
  {
    "title": "Documents & Charters",
    "link": "https://ir.allogene.com/Documents-and-Charters",
    "timestamp": "unknown"
  },
  {
    "title": "Board of DirectorsManagementCommittee CompositionSEC FilingsResourcesInvestor FAQsEmail AlertsIR Inquiry",
    "link": "https://allogene.com/about-us#board-of-directors",
    "timestamp": "unknown"
  },
  {
    "title": "Board of Directors",
    "link": "https://allogene.com/about-us#board-of-directors",
    "timestamp": "unknown"
  },
  {
    "title": "Management",
    "link": "https://allogene.com/about-us#management-team",
    "timestamp": "unknown"
  },
  {
    "title": "Committee Composition",
    "link": "https://ir.allogene.com/committee-composition",
    "timestamp": "unknown"
  },
  {
    "title": "SEC Filings",
    "link": "https://ir.allogene.com/sec-filings",
    "timestamp": "unknown"
  },
  {
    "title": "Resources",
    "link": "https://ir.allogene.com/investor-faqs",
    "timestamp": "unknown"
  },
  {
    "title": "Investor FAQs",
    "link": "https://ir.allogene.com/investor-faqs",
    "timestamp": "unknown"
  },
  {
    "title": "Email Alerts",
    "link": "https://ir.allogene.com/email-alerts",
    "timestamp": "unknown"
  },
  {
    "title": "IR Inquiry",
    "link": "https://ir.allogene.com/investor-contacts",
    "timestamp": "unknown"
  },
  {
    "title": "\u00a92025 Allogene TherapeuticsTERMS OF USEPRIVACY NOTICE",
    "link": "https://www.allogene.com/terms-of-use",
    "timestamp": "unknown"
  },
  {
    "title": "\u00a92025 Allogene TherapeuticsTERMS OF USEPRIVACY NOTICE",
    "link": "https://www.allogene.com/terms-of-use",
    "timestamp": "unknown"
  },
  {
    "title": "TERMS OF USE",
    "link": "https://www.allogene.com/terms-of-use",
    "timestamp": "unknown"
  },
  {
    "title": "PRIVACY NOTICE",
    "link": "https://allogene.com/privacy-notice/",
    "timestamp": "unknown"
  }
]